홈 카테고리 맞춤형시장조사 국제컨퍼런스 글로벌 파트너 메일링 서비스 회사소개회사소개 Contact Us
English Japaness Chinese
Home > 시장보고서 > 파머슈티컬 > 제약회사분석 > European Pharma/Biotech Contract Manufacturing Markets: A Strategic Outlook
카테고리
파머슈티컬 (4931)
감염질환 (349)
골질환 치료 (38)
당뇨병 (194)
백신 (181)
비만치료/다이어트 (44)
비처방 의약품 (152)
수의학 (17)
신경질환 (174)
신약개발 (1529)
암치료 (941)
약물전달 (185)
의약품 규제환경 (127)
정신질환 (86)
제네릭 의약품 (128)
제약회사분석 (523)
처방약 (165)
시장보고서

European Pharma/Biotech Contract Manufacturing Markets: A Strategic Outlook

리서치사 Frost & Sullivan
발행일 2008년 04월 상품코드 65336
페이지 정보
가격
US $ 6,500 ￦ 7,744,700 Web Access (Regional License)
US $ 7,000 ￦ 8,340,500 Hard Copy & Web Access (Regional License)


영문목차

Abstract

This research service provides a strategic outlook of the pharma/Biotech contract manufacturing markets in Europe. It includes technology trends, challenges, drivers, restraints, competitive structure, strategic recommendations and list of market participants.

Table of Contents

1 EUROPEAN PHARMA/BIOTECH CONTRACT MANUFACTURING MARKETS, EXECUTIVE SUMMARY

  • Summary of Key Findings
    • Key Conclusions

2 EUROPEAN PHARMA/BIOTECH CONTRACT MANUFACTURING MARKETS, TOTAL EUROPEAN PHARMA/BIOTECH CONTRACT MANUFACTURING MARKET

  • Introduction
    • Outsourcing in the Pharma/Biotech Industry: There is no Alternative
    • The Role of CMOs in the Pharma/Biotech Industry
    • Scope and Segmentation
    • Market Overview
    • Technology Trends
  • Market Engineering Research
    • Industry Challenges
    • Market Drivers
    • Market Restraints
  • Competitive Analysis
    • Competitive Structure
    • Trends in the Biotech Contract Manufacturing Market

3 EUROPEAN PHARMA/BIOTECH CONTRACT MANUFACTURING MARKETS, STRATEGIC RECOMMENDATIONS

  • Strategic Recommendations
    • Recommendations to Market Participants

4 EUROPEAN PHARMA/BIOTECH CONTRACT MANUFACTURING MARKETS, DATABASE OF KEY INDUSTRY PARTICIPANTS

  • Key Industry Participants
    • DKIP

5 EUROPEAN PHARMA/BIOTECH CONTRACT MANUFACTURING MARKETS, DECISION SUPPORT DATABASES

  • Decision Support Databases
    • Government Investment in Biotechnology
    • Pharmaceutical R&D Expenditure
    • EPO Biotechnology Patents
Back to Top